SentryX is happy to share that the first patient has been treated with its implantable anesthetic for spine surgery, BR-003. This event stands as a major landmark in SentryX’s first-in-human trial. A special thanks to the Elisabeth Tweesteden Hospital in Tilburg and all others involved to make this happen.

The phase 1b trial consist of two cohorts of six patients with an independent safety review in between. It will take only a few months until we see the first interim results, and we will keep you posted.